European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 36 citations · 28 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineMolecular ImagingPositron Emission TomographyRadiotracer DevelopmentReceptor ImagingTargeted Imaging AgentsTargeted RadiopharmaceuticalsTumor ImagingNanobody DiscoveryNanoparticle RadiotracersPd-l1 BlockadePet RadiopharmaceuticalsPet TracersPilot Study DesignReceptor Targeted RadiotracersTargeted Radionuclide Imaging
28
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp et al. · The Lancet · 2016 · 4.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · New England Journal of Medicine · 2018 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +16
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +17